Appen (APX) reported FY21 results today that were a miss to expectations while they also removed FY22 guidance, instead putting in longer dated revenue guidance. We are cutting our small 3% position.
We are increasing our existing position in Xero (XRO) by a further 2% into current weakness, taking it to a 7% portfolio weighting.